Stryker enters $701M deal to buy Canadian imaging technology firm | PerkinElmer announces $1.3B acquisition of German diagnostics firm | OpGen reaches supply agreement with Thermo Fisher
June 20, 2017
ADVAMED SmartBrief
News for medical technology professionals
Top Story
Stryker enters $701M deal to buy Canadian imaging technology firm
Stryker will pay approximately $701 million for NOVADAQ Technologies, a Canadian maker of fluorescent imaging technology for blood flow visualization, in a definitive deal that represents a 96% premium on NOVADAQ's closing share price on June 16. The acquisition, which is expected to be completed at the end of the third quarter, is subject to approval by NOVADAQ shareholders and other customary closing conditions.
Becker's Spine Review (6/19),  MiBiz (Michigan) (6/19) 
LinkedIn Twitter Facebook Google+ Email
Want to sell in China? Here's what you need to do.
The China Food and Drug Administration requirements can be intimidating. Manufacturers must comply with regulatory and clinical requirements before placing their device on the market. Emergo gives an overview of China's registration process in this 4-minute video. WATCH THE VIDEO NOW.
Business & Market Trends
PerkinElmer announces $1.3B acquisition of German diagnostics firm
Massachusetts-based scientific instruments maker PerkinElmer reached a deal to acquire German medical diagnostics company Euroimmun Medical Laboratory Diagnostics AG for $1.3 billion in cash. The acquisition, which is expected to be completed in the fourth quarter, will allow PerkinElmer to expand into autoimmune, infectious disease and allergy diagnostic markets.
MedCity News (6/19),  The Wall Street Journal (tiered subscription model) (6/19) 
LinkedIn Twitter Facebook Google+ Email
OpGen reaches supply agreement with Thermo Fisher
OpGen and Thermo Fisher Scientific have reached a supply agreement to commercialize OpGen's Acuitas Rapid Test for Pathogen ID in combination with Thermo Fisher's new mid-throughput real-time PCR system. OpGen disclosed no further terms of the deal, nor which Thermo Fisher system is part of the agreement.
GenomeWeb Daily News (free registration) (6/19) 
LinkedIn Twitter Facebook Google+ Email
Mazor Robotics announces leadership changes
Mazor Robotics appointed Oren Zarchin to lead its newly created Product Development Group and Eli Zehavi to head its newly established Advanced Technology Group. The company has also given additional roles to Christopher Prentice, CEO of its US subsidiary, as chief commercial officer, and to Chief Financial Officer Sharon Levita as vice president of business operations; Joshua Belkar has also been tapped to serve as vice president of operations and service.
Becker's Spine Review (6/19) 
LinkedIn Twitter Facebook Google+ Email
New CEO named by Clear Guide Medical
Bob Cathcart has been tapped to serve as CEO of Johns Hopkins spinout Clear Guide Medical. Cathcart, who most recently served as an executive at Hansen Medical, replaces Dorothee Heisenberg, who will become executive vice president. (6/19) 
LinkedIn Twitter Facebook Google+ Email
Fresh Look with Medical Design & Outsourcing
Battery-free pacemaker successfully powers the heart
Medical Design and Outsourcing
A wireless, battery-free pacemaker has shown success in powering the heart in pig models, according to researchers from Rice University and the Texas Heart Institute. The pacemaker, designed by lead researcher Aydin Babakhani, gets its energy wirelessly from radio frequency radiation transmitted from an external battery pack a few centimeters away. The implantable chip is less than 4 mm wide and uses a receiving antenna, an AC-to-DC rectifier, a power management unit and a pacing activation signal. Read the story.
LinkedIn Twitter Facebook Google+ Email
Science & Health
Study shows positive results for tibial base of DePuy Synthes' Attune system
A 30-patient study by the Canadian Radiostereometric Analysis Network showed stable fixation in knee replacement with the tibial base of the Attune system from Johnson & Johnson subsidiary DePuy Synthes. Over two years, the tibial base migrated an average of 0.02 mm in the superior-inferior direction, with an average maximum total point motion of 0.21 mm and average micromotion of 0.17 mm, according to results presented at the Canadian Orthopaedic Association's annual meeting.
Medtech Insight (free registration) (6/19) 
LinkedIn Twitter Facebook Google+ Email
MDxHealth, QUT bluebox enter scientific deal on oral cancer test
A scientific agreement between MDxHealth and QUT bluebox, the Queensland University of Technology's commercialization arm, will evaluate and develop a liquid biopsy epigenetic assay for early oral cancer detection. Under the deal, the first licensing option for commercial diagnostic rights will go to MDxHealth; proceeds will be used for research and translational activities at the university and MDxHealth's urologic cancer diagnostics research and development pipeline.
GenomeWeb Daily News (free registration) (6/19) 
LinkedIn Twitter Facebook Google+ Email
Emerging Technologies
FDA clears Meditech Spine's intervertebral body device
Meditech Spine obtained clearance from the FDA for its Talos Lumbar (HA) Peek IBF, an intervertebral body device for patients with lumbar degenerative disc disease who have up to grade 1 spondylolisthesis at one or two contiguous levels from L2 to S1. The device may be used with autograft or allograft composed of corticocancellous or cancellous bone graft.
Becker's Spine Review (6/19) 
LinkedIn Twitter Facebook Google+ Email
Government & Regulatory
CBO estimates costs of implementing user fee reauthorization bill
The FDA would require appropriations worth $1.2 billion from 2018 to 2022 to implement changes in the Senate's user fee reauthorization bill, according to a cost estimate released by the Congressional Budget Office. Medical device program changes that would be implemented under the bill would add $243 million to the FDA's costs and require the agency to add at least 200 full-time-equivalent positions, the CBO said.
Regulatory Focus (6/19) 
LinkedIn Twitter Facebook Google+ Email
Mass. governor to propose $500M medtech, biotech initiative
Massachusetts Gov. Charlie Baker is expected to unveil this week a proposal for a five-year, $500 million life sciences initiative focused on medtech and biotech companies. The initiative would include capital spending worth up to $295 million and tax incentives worth up to $150 million for companies that provide new jobs.
The Boston Globe (tiered subscription model) (6/19) 
LinkedIn Twitter Facebook Google+ Email
AdvaMed Events and Education
Reimbursement 101: A Primer on Medical Device Reimbursement
June 27-28 | Washington, D.C.
During this workshop, you will be provided with the roadmap and practical applications to successfully navigate the many potential reimbursement pitfalls. After an overview of current reimbursement issues, you'll hear from industry veterans and reimbursement professionals who will discuss case studies and real-life scenarios. Learn more.
LinkedIn Twitter Facebook Google+ Email
Start saving with the AdvaMed Purchasing Group
The AdvaMed Purchasing Group is a new member-only benefit that helps companies purchase the very best goods and services from nationally recognized suppliers at the very best cost, using a trusted and proven vetting system and the collective purchasing power of our membership. Participation is free for AdvaMed members, and there are no minimum commitments. Get started today.
LinkedIn Twitter Facebook Google+ Email
Learn more about AdvaMed:
About AdvaMed | Join | Courses | Events | Newsroom
powered by
Reimbursement/Health Economics Analyst
Sr. Director, Global Market Access
Engineer Level 3, Sustaining Design Quality
TERUMO BCT - Lakewood, CO
Medical Technologist
With ordinary talent and extraordinary perseverance, all things are attainable.
Thomas Fowell Buxton,
politician and abolitionist
LinkedIn Twitter Facebook Google+ Email
Sign Up
SmartBrief offers 200+ newsletters
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Advertising  -  Wynn Hansen
P: 202.470.1149
Jobs Contact  -
Editor  -  Lisa Gough
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2017 SmartBrief, Inc.®
Privacy policy |  Legal Information